デフォルト表紙
市場調査レポート
商品コード
1539338

肥満手術デバイス市場:世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Obesity Surgery Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033


出版日
ページ情報
英文 250 Pages
納期
2~5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
肥満手術デバイス市場:世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年08月20日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の肥満手術デバイス市場に関する詳細な調査レポートを発行し、市場促進要因・動向・機会・課題などの市場力学に関する詳細な洞察を提供しました。当レポートは、市場構造と将来展望の徹底的な理解を提供することを目的としており、競合情勢の中で優位に立ちたいと考えている業界関係者のニーズに応えます。

主な洞察

  • 世界市場収益(2022年):19億米ドル
  • 推定市場価値(2033年):32億米ドル
  • 世界市場成長率(CAGR 2022-2033):6.0%

肥満手術デバイスの世界市場- 調査範囲

肥満手術デバイス市場は、肥満症の治療を目的とした外科手術に使用される機器の生産と流通に焦点を当てています。これらの機器は、特に小児と成人において増加する肥満の世界の蔓延を管理する上で極めて重要であり、糖尿病、心血管疾患、特定のがんなどの肥満に関連する健康問題に対するヘルスケアセクターの対応に不可欠です。

市場成長の促進要因:

子供と成人における肥満の発生率の増加

世界的に小児および成人の肥満の有病率が上昇していることが、肥満手術デバイスの需要を牽引する重要な要因となっています。食生活の乱れや運動量の減少が肥満率の急上昇につながっており、今後も市場成長の主な促進要因になると予想されます。例えば、ユニセフの2022年版世界肥満アトラスによると、2030年までにインドだけでも2,700万人以上の子供が肥満になると予想されています。この憂慮すべき統計は、効果的な肥満管理戦略の必要性が高まっていることを浮き彫りにしており、肥満手術用機器の世界市場に拍車をかけています。

ヘルスケア支出の増加と意識向上

世界的に、特に新興経済諸国と先進経済諸国においてヘルスケアコストが上昇する中、肥満の管理と治療に対する関心が高まっています。一人当たりの医療費の増加は、個人や医療提供者が質の高い治療オプションを求めるため、高度な肥満手術デバイスの採用を促進すると予想されます。さらに、肥満に伴う糖尿病、心血管疾患、脳卒中などの深刻な健康リスクに対する肥満者の意識の高まりが、肥満手術デバイスの需要を押し上げると予想されます。

政府のキャンペーンと低侵襲手術

肥満とその結果についての認識を高めるための政府主導のキャンペーンも、市場の成長に寄与しています。マハラシュトラ州政府の支援を受けたインドのLaparoObesoセンターのプロジェクトのような取り組みは、遠隔地の人々に肥満と糖尿病について教育することを目的としています。同様に中国では、中国栄養学会の肥満予防管理部門が肥満の危機に対処するための啓発キャンペーンを展開しています。さらに、低侵襲の減量手術への嗜好が高まっていることも、市場をさらに促進すると予想されます。

市場の課題

高い生産コストと限られた財政支援

市場の潜在力にもかかわらず、肥満手術器具の研究開発・生産コストが高いことが大きな課題となっています。臨床試験を含む研究開発活動に必要な多額の財政投資は、製造業者にとって抑止力になり得る。胃スリーブ手術、胃バイパス手術、胃バンド調整術などの外科手術の費用が高いことも、市場の成長を制限する可能性があります。これらの高額な手術に対する十分な財政支援がないため、特にヘルスケア資金が限られている地域では、肥満手術デバイスの導入が制限される可能性があります。

本レポートで扱う主な質問

  • 世界の肥満手術デバイス市場の成長を促進する主な要因は何か?
  • 肥満手術デバイスの採用をリードしている消費者層は?
  • 手術技術の進歩は競合情勢にどのような影響を与えているか?
  • 肥満手術デバイスの世界市場における主要企業はどこか、また市場ポジションを維持するためにどのような戦略をとっているのか?
  • 世界の肥満手術デバイス市場における新たな動向と将来性は?

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 付加価値の洞察

  • 生産戦略
  • ボリューム消費
  • 生産コスト
  • パイプライン評価
  • 特許分析
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
  • 2024年の市場シナリオ

第7章 世界市場の(数量)分析

  • 市場(数量)分析、2019~2023年
  • 市場(数量)予測、2024~2033年
    • 前年比成長動向分析

第8章 世界市場- 価格分析

  • 医療機器/インプラント別の地域別価格分析
  • 価格の内訳
    • メーカーレベル
    • ディストリビューターレベル
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場の需要(金額および規模)分析

  • 市場(金額)分析、2019~2023年
  • 市場(金額)予測、2024~2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 医療機器/インプラント別:世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模(金額および数量)分析、2019~2023年
  • 市場規模(金額および数量)分析と予測、2024~2033年
    • 胃内バルーン
    • 胃バンド
    • ステープルデバイス
  • 医療機器・インプラント別市場の魅力分析

第11章 エンドユーザー別:世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模(金額)分析、2019~2023年
  • 市場規模(金額)分析と予測、2024~2033年
    • 病院
    • 専門クリニック
    • 外来手術センター
  • エンドユーザー別市場の魅力分析

第12章 地域別:世界市場分析

  • イントロダクション
  • 市場規模(金額および数量)分析、2019~2023年
  • 市場規模(金額および数量)分析と予測、2024~2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ(中東・アフリカ)
  • 地域別市場の魅力分析

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 東アジア市場分析

第17章 南アジア市場分析

第18章 オセアニア市場

第19章 中東・アフリカ(中東・アフリカ)市場分析

第20章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Johnson &Johnson
    • Medtronic, Inc.
    • Apollo Endosurgery Inc.
    • Aspire Bariatrics
    • Spatz FGIA Inc.
    • MetaCure
    • IntraPace Inc.
    • Other

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP2894

Persistence Market Research has recently published an in-depth report on the global obesity surgery devices market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a thorough understanding of the market structure and future outlook, catering to the needs of industry stakeholders looking to stay ahead in a competitive landscape.

Key Insights:

  • Global Market Revenue (2022): US$ 1.9 Billion
  • Estimated Market Value (2033): US$ 3.2 Billion
  • Global Market Growth Rate (CAGR 2022-2033): 6.0%

Global Obesity Surgery Devices Market - Report Scope:

The obesity surgery devices market focuses on the production and distribution of devices used in surgical procedures aimed at treating obesity. These devices are critical in managing the increasing global prevalence of obesity, particularly in children and adults, and are integral to the healthcare sector's response to obesity-related health issues such as diabetes, cardiovascular diseases, and certain cancers.

Market Growth Drivers:

Increasing Incidence of Obesity in Children and Adults

The rising prevalence of obesity among children and adults worldwide is a significant factor driving the demand for obesity surgery devices. Poor dietary habits and reduced physical activity are leading to a surge in obesity rates, which is expected to remain a key driver of market growth. For instance, according to UNICEF's World Obesity Atlas for 2022, by 2030, more than 27 million children in India alone are expected to be obese. This alarming statistic underscores the growing need for effective obesity management strategies, fueling the global market for obesity surgery devices.

Rising Healthcare Spending and Awareness

As healthcare costs rise globally, particularly in emerging and developed economies, there is an increasing emphasis on obesity management and treatment. Higher per capita healthcare spending is anticipated to drive the adoption of advanced obesity surgery devices, as individuals and healthcare providers seek high-quality treatment options. Moreover, growing awareness among overweight individuals about the severe health risks associated with obesity, such as diabetes, cardiovascular diseases, and strokes, is expected to boost the demand for obesity surgery devices.

Government Campaigns and Minimally Invasive Procedures

Government-led campaigns to raise awareness about obesity and its consequences are also contributing to market growth. Initiatives like the LaparoObeso Centre's project in India, supported by the Maharashtra State Government, aim to educate remote populations about obesity and diabetes. Similarly, in China, the Obesity Prevention and Control Section of the Chinese Nutrition Society has launched awareness campaigns to address the obesity crisis. Additionally, the increasing preference for minimally invasive weight loss procedures is expected to further propel the market.

Market Challenges:

High Production Costs and Limited Financial Support

Despite the market's potential, the high cost of research, development, and production of obesity surgery devices poses a significant challenge. The substantial financial investment required for R&D activities, including clinical trials, can be a deterrent for manufacturers. The high cost of surgical procedures, such as gastric sleeve surgery, gastric bypass surgery, and adjustable gastric banding, may also limit market growth. The lack of adequate financial support for these expensive surgeries can restrict the adoption of obesity surgery devices, particularly in regions with limited healthcare funding.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global obesity surgery devices market?
  • Which consumer segments are leading the adoption of obesity surgery devices?
  • How are advancements in surgical technology influencing the competitive landscape?
  • Who are the key players in the global obesity surgery devices market, and what strategies are they employing to maintain their market position?
  • What are the emerging trends and future prospects in the global obesity surgery devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global obesity surgery devices market are focusing on innovation, strategic partnerships, and expanding their product portfolios to maintain a competitive edge. Companies are investing heavily in R&D to develop next-generation devices that offer improved safety, efficacy, and patient outcomes. Collaborations with healthcare providers and government agencies are enhancing market credibility and driving the adoption of these advanced surgical devices. Additionally, leveraging digital marketing and targeted outreach to both healthcare professionals and patients is key to strengthening market positioning and consumer engagement.

Key Companies Profiled:

  • Johnson & Johnson
  • Medtronic, Inc.
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics
  • Spatz FGIA Inc.
  • MetaCure
  • IntraPace Inc.
  • Other

Key Segments Covered in Obesity Surgery Devices Industry Research

Medical Devices/ Implants:

  • Gastric Balloons
  • Gastric Bands
  • Stapling Devices

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage/Taxonomy
  • 2.2. Market Definition/Scope/Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation/Development Trends

4. Value Added Insights

  • 4.1. Production Strategy
  • 4.2. Volume Consumption
  • 4.3. Production Cost
  • 4.4. Pipeline Assessment
  • 4.5. Patent Analysis
  • 4.6. PESTEL Analysis
  • 4.7. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Technological Innovation in Surgery Devices
    • 5.2.2. Regulatory Imposition
    • 5.2.3. Increasing Spending on Research and Development
    • 5.2.4. Increasing Prevalence of Obesity
    • 5.2.5. Increasing Chronic Diseases Due to Obesity
    • 5.2.6. High Rate of Manufacturing
    • 5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market- Pricing Analysis

  • 8.1. Regional Pricing Analysis By Medical Devices/Implants
  • 8.2. Price Break up
    • 8.2.1. Manufacturer Level
    • 8.2.2. Distributor Level
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Medical Devices/Implants

  • 10.1. Introduction/Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Medical Devices/Implants, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Medical Devices/Implants, 2024-2033
    • 10.3.1. Gastric Balloons
    • 10.3.2. Gastric Bands
    • 10.3.3. Stapling Devices
  • 10.4. Market Attractiveness Analysis By Medical Devices/Implants

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 11.1. Introduction/Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Specialty Clinics
    • 11.3.3. Ambulatory Surgical Centers
  • 11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 12.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East and Africa (MEA)
  • 12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Medical Devices/Implants
    • 13.3.3. By End User
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Medical Devices/Implants
    • 13.4.3. By End User
  • 13.5. Market Trends
  • 13.6. Drivers and Restraints - Impact Analysis
  • 13.7. Key Players - Intensity Mapping
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market Analysis
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Medical Devices/Implants
        • 13.8.1.2.2. By End User
    • 13.8.2. Canada Market Analysis
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Medical Devices/Implants
        • 13.8.2.2.2. By End User

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Medical Devices/Implants
    • 14.3.3. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Medical Devices/Implants
    • 14.4.3. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Key Players - Intensity Mapping
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Medical Devices/Implants
        • 14.8.1.2.2. By End User
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Medical Devices/Implants
        • 14.8.2.2.2. By End User
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Medical Devices/Implants
        • 14.8.3.2.2. By End User

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Medical Devices/Implants
    • 15.3.3. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Medical Devices/Implants
    • 15.4.3. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Key Players - Intensity Mapping
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Medical Devices/Implants
        • 15.8.1.2.2. By End User
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Medical Devices/Implants
        • 15.8.2.2.2. By End User
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Medical Devices/Implants
        • 15.8.3.2.2. By End User
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Medical Devices/Implants
        • 15.8.4.2.2. By End User
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Medical Devices/Implants
        • 15.8.5.2.2. By End User
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Medical Devices/Implants
        • 15.8.6.2.2. By End User
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Medical Devices/Implants
        • 15.8.7.2.2. By End User

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Medical Devices/Implants
    • 16.3.3. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Medical Devices/Implants
    • 16.4.3. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Key Players - Intensity Mapping
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Medical Devices/Implants
        • 16.8.1.2.2. By End User
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Medical Devices/Implants
        • 16.8.2.2.2. By End User
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Medical Devices/Implants
        • 16.8.3.2.2. By End User

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Medical Devices/Implants
    • 17.3.3. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Medical Devices/Implants
    • 17.4.3. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Key Players - Intensity Mapping
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Medical Devices/Implants
        • 17.8.1.2.2. By End User
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Medical Devices/Implants
        • 17.8.2.2.2. By End User
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Medical Devices/Implants
        • 17.8.3.2.2. By End User
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Medical Devices/Implants
        • 17.8.4.2.2. By End User

18. Oceania Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Medical Devices/Implants
    • 18.3.3. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Medical Devices/Implants
    • 18.4.3. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Key Players - Intensity Mapping
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Medical Devices/Implants
        • 18.8.1.2.2. By End User
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Medical Devices/Implants
        • 18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Medical Devices/Implants
    • 19.3.3. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Medical Devices/Implants
    • 19.4.3. By End User
  • 19.5. Market Trends
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Key Players - Intensity Mapping
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Medical Devices/Implants
        • 19.8.1.2.2. By End User
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Medical Devices/Implants
        • 19.8.2.2.2. By End User
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Medical Devices/Implants
        • 19.8.3.2.2. By End User
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Medical Devices/Implants
        • 19.8.4.2.2. By End User

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Competition Benchmarking
  • 21.3. Competition Deep Dive
    • 21.3.1. Johnson & Johnson
      • 21.3.1.1. Overview
      • 21.3.1.2. Product Portfolio
      • 21.3.1.3. Sales Footprint
      • 21.3.1.4. Key Financials
      • 21.3.1.5. SWOT Analysis
      • 21.3.1.6. Strategy Overview
    • 21.3.2. Medtronic, Inc.
      • 21.3.2.1. Overview
      • 21.3.2.2. Product Portfolio
      • 21.3.2.3. Sales Footprint
      • 21.3.2.4. Key Financials
      • 21.3.2.5. SWOT Analysis
      • 21.3.2.6. Strategy Overview
    • 21.3.3. Apollo Endosurgery Inc.
      • 21.3.3.1. Overview
      • 21.3.3.2. Product Portfolio
      • 21.3.3.3. Sales Footprint
      • 21.3.3.4. Key Financials
      • 21.3.3.5. SWOT Analysis
      • 21.3.3.6. Strategy Overview
    • 21.3.4. Aspire Bariatrics
      • 21.3.4.1. Overview
      • 21.3.4.2. Product Portfolio
      • 21.3.4.3. Sales Footprint
      • 21.3.4.4. Key Financials
      • 21.3.4.5. SWOT Analysis
      • 21.3.4.6. Strategy Overview
    • 21.3.5. Spatz FGIA Inc.
      • 21.3.5.1. Overview
      • 21.3.5.2. Product Portfolio
      • 21.3.5.3. Sales Footprint
      • 21.3.5.4. Key Financials
      • 21.3.5.5. SWOT Analysis
      • 21.3.5.6. Strategy Overview
    • 21.3.6. MetaCure
      • 21.3.6.1. Overview
      • 21.3.6.2. Product Portfolio
      • 21.3.6.3. Sales Footprint
      • 21.3.6.4. Key Financials
      • 21.3.6.5. SWOT Analysis
      • 21.3.6.6. Strategy Overview
    • 21.3.7. IntraPace Inc.
      • 21.3.7.1. Overview
      • 21.3.7.2. Product Portfolio
      • 21.3.7.3. Sales Footprint
      • 21.3.7.4. Key Financials
      • 21.3.7.5. SWOT Analysis
      • 21.3.7.6. Strategy Overview
    • 21.3.8. Other
      • 21.3.8.1. Overview
      • 21.3.8.2. Product Portfolio
      • 21.3.8.3. Sales Footprint
      • 21.3.8.4. Key Financials
      • 21.3.8.5. SWOT Analysis
      • 21.3.8.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology